BARDA Plans Four-Pronged Approach To Future Pandemics
Executive Summary
A new paper from the US Biomedical Advanced Research and Development Authority (BARDA) suggests a future pandemic strategy that leans heavily on flexibility, collaborations with industry, and swift regulatory authorization.
You may also be interested in...
Omnibus Funding Bill Provides Provisions For Future Pandemic Preparedness
As a part of the end-of year omnibus bill, BARDA and FDA received funding to boost US’s domestic manufacturing of biomedical devices to prepare for future pandemics.
BARDA Releases Five-Year Strategic Plan
The Biomedical Advanced Research and Development Authority says lessons learned from the pandemic has better prepared the agency to respond to future health emergencies, including a new infectious disease division.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.